Floatz logo

ima950

Glioma, Astrocytic

Nicholas ButowskivaccinePhase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
26/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Glioma, Astrocytic cohort.

Asset / SponsorPhaseRating
Carboplatin
Oliver Jonas
Phase 2BB
Irinotecan
Julie Krystal
Phase 2BB
(+)-VINCRISTINE
Novartis Pharmaceuticals
Phase 2BB
gsk1120212
Novartis Pharmaceuticals
Phase 4BB
Dabrafenib
Novartis Pharmaceuticals
Phase 4BB

View all 40 →

Same molecule, other indications

ima950 is also rated in:

central nervous system neoplasmDormant
CCC
Indicative ·
52 / 100
View asset →
central nervous system neoplasmDormant
CC
Indicative ·
46 / 100
View asset →
adult glioblastomaDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →